Aspen Aerogels IncASPN
Price$5.48

Financial Snapshot

Revenue, profitability, returns, debt, and capital allocation

Revenue $202.1M-55.4% YoYTTM through 30 Jun 2026
Net Income -$126.2M-1,043.6% YoYTTM through 30 Jun 2026
Free Cash Flow $34.4MTTM through 30 Jun 2026

Margins

Current
Gross Margin17.1%
EBITDA Margin-55.7%
Operating Margin-139.5%
Net Margin-62.5%

Returns

-165.4%ROE
-95.8%ROA

Balance Sheet Health

Debt / Equity0.45x
Current Ratio3.90x
Net Debt-$51.9Mnet cash position
Cash & Equivalents$151.7M

Quality Metrics

Altman Z-Score-2.61
Piotroski F-Score3 / 9
FCF Margin17.0%
Earnings-Beat Rate25.0%

Multi-Year Trend

Revenue
'19'20'21'22'23'24'25
FY2025: $271.1M
Diluted EPS-$1.52TTM
'15'20'21'22'23'24'25
FY2025: $-4.73

Dividend

No dividend

Capital Allocation

R&D Spend$11.2M
Capex Intensity7.3%
All values are periodic snapshots, not live quotes. Source dates are shown for reference.

Filing Detail Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Sign in / Sign up
AI-assisted, source-linked narrative; figures from company filings (SEC EDGAR) and market data. Dates shown per section. Not investment advice. Terms of Use.